Biocon Biologics

Biocon Biologics announces key leadership appointments

Read more

Biocon Biologics gets positive CHMP opinion for YESAFILI, biosimilar Aflibercept

Read more

Biocon Biologics launches Hulio biosimilar in US

Read more

CCI clears Edelweiss-Biocon Biologics deal

Read more

Serum and Biocon Biologics sign agreement to restructure equity investment

Read more

Biocon Biologics wins Bioprocessing Excellence in South Asia Award at ABEA 2023

Read more

Biocon Biologics appoints Shreehas Tambe as Managing Director and CEO

Read more

Biocon Biologics completely acquires Viatris’s global biosimilars business

Read more

Biocon Biologics outlicenses two biosimilar assets to Yoshindo for commercialisation in Japan

Read more

Biocon Sdn Bhd enters Malaysia Book of Records

Read more